| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue | (260) | 260 |
-
|
-
| | | Gross Profit | 260 | (260) |
-
|
-
| | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,565 | 3,569 | 332 | 699 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 242 | 565 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,547) | (4,394) | (332) | (699) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 251 | (2,207) | 70 | 840 | | Earnings Before Interest And Taxes | (2,379) | (6,601) | (262) | 141 | | Interest Expense | (887) | 699 | 188 | 271 | | Income Before Tax | (1,493) | (7,299) | (450) | (130) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,493) | (7,299) | (450) | (130) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (0) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,493) | (7,299) | (450) | (130) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,493) | ($7,299) | ($450) | ($130) |
|
1.52% Nasdaq 0.00%
Income Statement
